Objective A randomized controlled trial was used to objectively evaluate the clinical efficacy of acupoint catgut embedding in the treatment of women with overactive bladder(OAB)by analyzing the overactive bladder symptom score(OABSS)and urination diary(average24-hour urination times,average 24-hour nocturia times,average 24-hour urinary incontinence times and each urination volume).To provide evidence for the clinical application of acupoint catgut embedding in female OAB.MethodsThis subject adopts 64 subjects with OAB were randomly divided into treatment group and control group with 32 cases each.The control group was treated with western medicine: oral solifenacin 5 mg/time,1 time/day,the course of treatment was 2 weeks,the treatment group was intervened by three acupoint catgut embedding for Niaosanzhen(Zhongji,Guanyuan,Sanyinjiao),1 time/week,the course of treatment was 2 weeks,and both groups received behavioral therapy during the treatment period.By comparing the differences in symptom scores of overactive bladder and urination diary(average 24-hour urination times,average24-hour nocturia times,average 24-hour urinary incontinence times and each urination volume)before and after the intervention,the intra group control and inter group control were carried out,and oabss was followed up by telephone to evaluate the clinical efficacy of the two treatment schemes.Results1.Before treatment,there was no significant difference between the two groups in age,course of disease,OABSS score,average 24-hour urination times,average 24-hour nocturia times,average 24-hour urinary incontinence times and each urination volume(P > 0.05).2.OABSS score: the total score of OABSS after treatment decreased compared with that before treatment(P<0.05),and the total score of OABSS in the treatment group decreased more than that in the control group,the difference was statistically significant(P<0.05).The total score of OABSS in the follow-up period increased compared with that after treatment,but still lower than that before treatment,and the total score of OABSS in the treatment group increased less than that in the control group,the difference was statistically significant(P<0.05).3.Average 24-hour urination times: the average 24-hour urination times after treatment decreased compared with that before treatment(P<0.05),and the treatment group decreased more significantly than the control group,with a statistically significant difference(P<0.05).4.Average 24-hour nocturia times: the average 24-hour nocturia times after treatment decreased compared with that before treatment(P<0.05),and the decrease in the treatment group was more obvious than that in the control group,the difference was statistically significant(P<0.05).5.Average 24-hour urinary incontinence times: the average 24-hour urinary incontinence times after treatment decreased compared with that before treatment(P<0.05),and the decrease in the treatment group was more obvious than that in the control group,the difference was statistically significant(P<0.05).6.Each urination volume: the each urination volume after treatment increased compared with that before treatment(P<0.05),and the increase in the treatment group was more obvious than that in the control group,the difference was statistically significant(P<0.05).7.During the treatment period,the adverse reaction rate of the treatment group was lower than that of the control group.Conclusions1.Acupoint catgut embedding therapy and Western medicine treatment can improve OAB symptoms,reduce the number of micturition,nocturia and urinary incontinence,increase the amount of micturition each time,and alleviate lower urinary tract symptoms such as frequent micturition,urgency,nocturia and urinary incontinence.2.Acupoint catgut embedding is better than western medicine in the treatment of OAB,with lower incidence of adverse reactions and long-term effect. |